Introduction
Antipsychotics (APs) are widely prescribed to manage psychoses that occur with schizophrenia and bipolar disorder (Miyamoto et al., 2005) .
Initially thought to achieve their therapeutic outcome by blockade of central dopaminergic and serotonergic pathways, however, APs are now known to involve a wider range of receptor targets which may, at higher doses, impart advantageous as well as deleterious behavioural (Putten et al, 1991) and neurological sequelae (Wiklund et al., 2010) . Indeed, it is well established that at high doses, members of the typical class of APs, such as the phenothiazine chlorpromazine (CPZ) can be cytotoxic for different types of cell in culture (Dwyer et al., 2003) as well as inhibiting the proliferation of both normal and cancer cells (Nordenberg at al 1999) .
Whereas, other typical antipsychotics, which have different chemical structures, such as haloperidol (HAL) a butyrophenone, still have a similar clinical outcome as CPZ but do not, however, always have the same neurotoxic effects that are associated with high dosages of phenothiazines (Munyon et al.,1987; Galili-Mosberg et al., 2000) .
The mechanisms that underlie AP neurotoxicity remain unclear. They may be related to their direct actions as ligands on dopaminergic and serotonergic receptors (McGrath and Neifeld, 1985) , or indeed other receptor classes such as sigma receptors (Vilner et al., 1995) . Their neurotoxicity may result from disruptive actions on mitochondria and oxidative respiration (Dudani and Gupta, 1987) or occur via disruption of 5 cellular cholesterol metabolism (Dujovne and Zimmerman, 1969; Wiklund et al., 2010) . However, any in-vivo appreciation of the neurological functional sequelae of AP usage, whether with normal or overdosage is confounded by the fact that the access of these drugs to the CNS and their associated pharmacokinetics, are subject to the transport properties of the blood brain barrier (BBB).
The BBB controls the transport of metabolites, drugs and chemicals between the blood and brain compartments, in doing so it acts to both protect, but also maintain, the interstitial environment of the CNS (Abbott 2013 , Abbott et al 2010 Wilhem et al 2011) . Anatomically, the structure of the BBB comprises of a monolayer of brain micro-vascular endothelial cells joined by tight and adherent junctions (Weiss et al., 2009; Abbott et al 2010) . This physical arrangement ensures that the endothelial cells act to restrict the movement of microscopic particles (e.g. bacteria) and hydrophilic molecules into the cerebrospinal fluid (CSF) (Bernas et al., 2010; Abbott 2013 , Abbott et al 2010 . Once this barrier is breached, the CNS is exposed to potential insult by hazardous solutes and pathogens circulating in the blood (Abbott et al 2010) . In fact the BBB is functionally predisposed to prevent the entry of amphiphilic compounds such as APs into the CNS, which raises the question as to the mechanism by which these drugs actually gain access to the CNS and affect their therapeutic action (Abbott 2013 , Abbott et al 2010 Wilhem et al 2011) . This is a particularly pertinent problem since endothelial cells of the BBB possess 6 members of the ABC transporter family such as P-glycoprotein (CordonCardo et al., 1989; Abbott et al 2010) whose predominant function is to actively pump amphiphilic compounds out of cells. One possible mechanism by which APs accumulate in the CNS is that these drugs inhibit, or are not substrates, for P-glycoprotein of the BBB endothelial cells. Alternatively the membrane permeability of the APs may be sufficiently high such that their passive influx exceeds the capacity of Pglycoprotein to extrude them the . Another further mechanism by which APs may gain access to the CNS is that the drugs themselves are cytotoxic to the cells of the BBB with the resultant impairment in the barrier function allowing them access to the CNS.
It is unknown is to what extent that AP, especially at dosages at the higher end of their therapeutic window, affect the function of cells of the BBB, a phenomena that will have consequences for transport of these drugs across the BBB, their associated pharmacokinetics, as well as the overall effect of APs on CNS function and their clinical outcome. APs, at concentrations similar to those measured in the serum of highly dosed patients, are already established to induce gross permeability changes in the BBB; for example its permeability to FeCl3, mannitol and inulin are all enhanced by acute administration of 5µM CPZ (Pardridge et al., 1973; Ben-Shachar et al., 1994) , a phenomenon indicative of a BBB breach at a drug concentration similar to that occasionally measured in human serum (3µM, 1000ng/ml; Van Putten et al, 1991) , and.
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Since it is possible to isolate and culture the different cell types that constitute the BBB (Bernas et al., 2010) the primary aim of this study was to investigate the cellular and functional effects of two typical APs (CPZ and HAL) and two atypical APs: risperidone (RIS) and clozapine (CLZ), at the higher end of therapeutic levels, as well as those expected with over dosage, on a model system of the BBB. In particular, we wished to determine to what extent these drugs affect cell viability, programmed cell death, barrier permeability and to investigate putative mechanisms behind these processes. 
RESULTS
We first investigated the concentration dependence for the effect of two typical (CPZ and HAL) and two atypical (RIS and CLZ) APs on the viability of human brain microvascular endothelial cells (HBMECs).
2.1 Antipsychotics impair HBME cell viability Figure 1 show the relationships between drug concentrations and reduction of MTT and exclusion of trypan blue for HBMECs for 4 different time points (4hrs, 24hrs, 48hrs and 72hrs). At concentrations of AP at 10 µM or less, all the drugs significantly inhibited the ability of the cell population to reduce MTT relative to control (p<0.001, ANOVA). However, even at concentrations in excess of 0.3-1mM and with extended incubation times of 72hrs none of the drugs abolished MTT reduction, with ~ 20-30% of the cell population apparently resistant to the action of the APs. The inhibitory effects of the APs on the cells ability to reduce MTT were mirrored by a decreased ability of the cells to exclude trypan blue; data which indicates that a loss of plasma-membrane integrity of the cells is associated with their redox capability. For both the MTT and trypan blue exclusion assays, the concentration-effect relationships for HAL and RIS were best described by a monophasic relationship (equation 1, Fraction = 0). For CPZ and CLZ their concentration-effect relationships on MTT were best described by a biphasic relationship (equation 1) with the IC50 for the highest affinity components given in Figure 2 . The fraction of the high affinity components were 0.29 (0.14 to 0.44, 95% CI) and 0.34 (0.27 to 9 0.41, 95% CI) for CPZ and CLZ respectively. A monophasic equation (as compared to a biphasic using the F-test) best described the relationship between the concentrations of these drugs and the exclusion of trypan blue. Over the 72hr incubation period neither the drugs nor vehicle control produced a significant change in total cell count: cells excluding trypan blue + cells containing trypan blue. This data inundates that the proliferation rate of the cells was slow enough as not to be affected by the time courses of the experimental paradigms employed. To further clarify the temporal effects of the APs, the relationships between the percentage viability with 10µM of drug were plotted against the time of exposure (Fig. 3) . For all four APs tested, both MTT reduction and TB were significantly and negatively correlated with incubation time for a fixed drug concentration (r<-0.95, p<0.05 for all cases; Pearson one-tailed). The greatest drug effect was always demonstrated with the MTT assay (p<0.001, for each drug tested ANOVA); data again suggestive that a decrease in cellular redox status precedes the loss of cell plasma membrane integrity.
Antipsychotics condense chromatin
Cell visualised with transmission electron microscopy (TEM) revealed that vehicle treated cells appeared normal (Fig. 4) , whilst cells treated with antipsychotics had degraded organelles, vacuolated cytoplasm, nuclear breakdown, increased electron density and chromatin condensation; observations consistent with apoptosis. Qualitatively, these apoptotic effects appeared to be the most prominent in CPZ and CLZ treated cells, but least in those treated with RIS and HAL. The induction of apoptosis by the APs was supported by the observation of heterogeneous DAPI staining of the nuclei. After 24hrs incubation at their EC50s for viability, the APs led to ~50% of the nuclei to become heterogeneously stained: 50±2%, 51±0.3%, 46±2% and 46±0.5% for CPZ, HAL, RIS and CLZ respectively. 
Antipsychotics and the cell cycle
There was no discernible effect of the APs on the number of cells in the G0/G1 phase or the G2/G1 ratio of the cell cycle.
2.5 Antipsychotics activates Caspase-3, -8 and -9 Figure 6 shows, with the exception of RIS, the APs caused a significant increase in the activity of Caspases-3, -8 and -9 relative to the vehicle control (ANOVA).
2.6 Antipsychotics impair the transport properties of confluent monolayers.
When applied for 72hrs at their EC50 concentration for viability, both CLZ and CPZ greatly enhanced the permeability of Evans blue across HBMEC monolayers (Fig. 7) . In fact, an enhanced flux of Evans blue was observed even after 2hr incubation with the drugs at these concentrations.
Microscopic inspection of the endothelia monolayers revealed widespread disruption of monolayer structure and continuity, data which suggests these drug concentrations are too aggressive for the BBB to maintain functionality. In response to this situation, the experiments were repeated, but with the monolayers incubated at half the EC50 for each respective AP. Under these conditions, the permeation of Evans blue after 72hr incubation with AP was significantly decreased by both CPZ and CLZ However, in no case was 100% viability restored. 10mM glutathione also reversed the DNA damage produced by CLZ at its EC50 for viability as indicated by the Comet assay (Fig 5) .
DISCUSSION
The primary aim of this study was to investigate the cellular and functional effects of four antipsychotics (APs): two typical, CPZ and HAL, and two atypical, RIS and CLZ, on a HBMEC model of the BBB, in particular at concentrations similar to those seen with therapeutic over dosage in man as well as those commonly used in animal models. At concentrations of ~10µM and greater, all four drugs were found to adversely affect HBMEC function, with CPZ and CLZ the most potent, HAL and RIS lesser so. All four drugs impaired the ability of HBMECs to reduce MTT, an effect paralleled by a loss of plasma membrane integrity with increased uptake of trypan blue and leak of lactate dehydrogenase. At their EC50 concentrations for these effects, all four APs disrupted cellular ultrastructure and morphology. However, the same concentrations of drugs did not affect DNA breakage (except CPZ) as indicated by the alkali 14 Comet assay, nor did they affect Gamma-Histone H2AX staining or the cell cycle. HAL, CPZ and CLZ, but not RIS, did increase the activity of Caspases -3, -8 and -9 as well as promoting chromatin condensation and fragmentation, data indicative of apoptosis. These cytotoxic effects were associated with changes in the transendothelial permeability and electrical properties of a BBB model. The cytotoxic effects of these drugs were in part mediated by oxidative stress since their action was partially blocked with glutathione, a reductant well established to protect against oxidative stress associated cytoxicity (Slater et al 1995) .
Mechanisms of cytotoxicity
Phospholipidosis and bioenergetic impairment are two established mechanisms by which antipsychotics induce cytotoxicity. Amphiphilic compounds such as antipsychotics can promote phospholipidosis (Halliwell, 1997) , as well as interact directly with cell membrane sterols (Dujovne and Zimmerman, 1969; Erik et al., 2010) either of which could induce the cytotoxic changes we observed.
It is also well-established that antipsychotics can impair cellular bioenergetics (Dwyer et al., 2005) . These effects need not be secondary to that of phospholipidosis; since, CPZ, HAL, RIS and CLZ are known to affect mitochondrial function by an inhibition of Complex I of the electron transport chain, with IC50's of ~35µM for CPZ and HAL, ~65 µM for RIS and >200µM for CLZ in isolated mitochondrial preparations (Burkhardt et al., 1993; Modica-Napolitano et al., 2003) . CPZ can also impair succinate-cytochrome C reductase activity as well as acting as a mitochondrial uncoupler (Modica-Napolitano et al., 2003) . Indeed the inhibition of Complex I within neurons of the cortex by neuroleptics has previously been proposed to partly explain the extrapyramidal symptoms seen with this class of drugs (Maurer & Möller, 1997) .
A consequence of mitochondrial function disruption is the induction of apoptosis. The fact that in our study the APs led to nuclei heterogeneously stained with DAPI, chromatin condensation, as well as degraded organelles and vacuolated cytoplasm, supports an apoptotic rather than necrotic mechanism of AP cytotoxicity. An idea also supported by the ability of HAL, CPZ and CLZ, but not RIS, to activate the caspases -3, -8 and -9; enzymes whose activation is strongly associated with the apoptotic cascade (Ola et al., 2011) . RIS may induce apoptosis via a noncaspase pathway.
The observation that the APs always had greater effect on MTT reduction than on TBE; suggests the cytotoxic effect is initially precipitated by impairment in the cellular redox status. This idea is consistent with a mitochondrial target of the APs and is supported by the following explanation of the conundrum as to why ~30-40% of any cell population may be explained by the fact that cells at certain stages of the cell cycle (Finkel and Hwang, 2009 ) are endowed with different metabolic profiles:
during the G1 phase, energy production occurs predominantly via mitochondrial aerobic respiration, whereas during S and G2 phases it 16 occurs predominantly by aerobic glycolysis (Schieke et al., 2008) . Our cell cycle analyses demonstrated that the populations of HBMECs we used
were not fixed at any particular stage of cell cycle but had cells in GO/G1, S and G2. Since Complex I of the mitochondrial electron transport chain is suggested to a major target for the APs we used, this notion implies that cells in the S1 and G2 phases (~40% present study) whose metabolic flux is predominantly glycolytic would be resilient to the cytotoxic effects of these drugs, where as those in the G1\G0 phase of cell cycle (~60% present study) would be prone. Since these percentages of cell cycle phase are almost identical to the respective proportion of cells resilient (~40%) or adversely affected (~60%) by the antipsychotics, is strong evidence in support of the cell cycle phase and its associated bioenergetic state affecting the cytotoxicity of antipsychotics in this HBMEC of the BBB.
Comparative potency of the antipsychotics After 72hr exposure, CPZ had the most potent affect of the four APs on MTT reduction, with an IC50 of <1µM (~1µM at 48hr) compared to 2µM for CLZ, 48µM for HAL and 56µM for RIS. This data implies that, for CPZ and CLZ at least, cytoxic effects of the BBB may occur with concentrations of these AP at the higher end of their clinical therapeutic window: 300 ng/ml (1µM) for CPZ and 700 ng/ml (2µM) for CLZ. The fact that the ability of both CLZ and CPZ to inhibit MTT reduction was biphasic in nature suggests that at least two sites of action exist for these two drugs. Interestingly the delays between cytotoxic induction and completion of apoptosis has been 18 described in other cellular systems e.g. 18hr for MPP + induced apoptosis in neuroblastoma (Fall & Bennett 1999) .
A similar ranked order of cytotoxic potency for these APs is reported for the phaemocytochroma cell line, PC12 after 48hr exposure; with IC50s of 60 µM and 110µM for CPZ and CLZ respectively, and ~200µM for both RIS and HAL (Dwyer et al., 2003) . In endothelial cells of the human umbilical vein (HUVECs) after 72hr exposure, CPZ was shown to be slightly less cytotoxic with an IC50 of 25µM, whereas HAL had no effect up to 400 µM (Wiklund et al., 2010) . It thus appears that HBMECs are exquisitely sensitive to CLZ and CPZ compared to HAL and RIS. Interestingly, the IC50
values for the cytotoxic effects of CPZ is similar to the value reported for its direct inhibitory effect on the activity of Complex I in isolated rat brain mitochondria: IC50 of <5µM (Rosenfeld et al., 2011) . Together, this evidence suggests that for CPZ to achieve a potency in HBMECs similar to that observed for its inhibition of Complex I in isolated mitochondria the drug must have easy access to the cytosol. Moreover, a predominantly mitochondrial effect of these drugs explains why a decrease in redox status, as monitored by the MTT assay, appears to be the primary event in the cytotoxic cascade described here.
The generation of ROS with the production of oxidative stress and damage is known to occur with agents that inhibit mitochondrial electron transport.
This fact is exemplified by our observation with Antimycin A which blocks complex II of the mitochondrial electron transport chain; an action well 19 documented to lead to ROS production. Our findings support this notion and indeed corroborate previous literature that demonstrates increased oxidative stress by APs such as HAL and CPZ in the CNS in-vivo (Reinke et al 2004) . Elevated ROS can act as a trigger for apoptosis (Slater et al 1995) as well as having direct cytotoxic effects on a variety of cellular proteins and processes. Our observation that exogenously supplied glutathione partly alleviates the decrease in MTT observed with the APs, as well as preventing DNA breakage as indicated by the Comet assay, is strong evidence for a role for oxidative stress in the mechanism of AP cytotoxicity. It is of note that only CPZ affected DNA breakage, an observation that presumably relates to the fact that it was the most potent drug studied.
One question is to how these drugs accumulate to high enough concentrations to be mitochondrial poisons since endothelial cells of the BBB possess members of the ABC transporter family such as Pglycoprotein (Cordon-Cardo et al., 1989) : proteins which act to pump amphiphilic compounds, like APs out of the cell and in the case of endothelial cells, out across the BBB (Hembury et al., 2008; Hemmelmann et al., 2012) . Our data suggests that the drugs we used are either not transported by P-glycoprotein or they inhibit its activity. Alternatively, these APs may possess passive membrane permeability so high such that their rate of influx is larger than, and overwhelms that, of the Pglycoprotein efflux pathway; a scenario already demonstrated for CPZ in 20 BBB models (Seelig, 2007) . Although these APs at ~30µM can stimulate the ATPase activity of P-glycoprotein and are perhaps substrates for transportation (Boulton et al., 2002) , the observation that at similar concentrations they actually inhibit the ability of this protein to extrude the amphiphilic molecule, RH123 from cells (Wang et al., 2006) at excessively high concentrations of APs subsequent damage to the BBB would make it leaky, not just to blood solutes and components with ensuing extravasation (Pardridge et al., 1973; Ben-Schachar et al., 1994) , were purchased from Sigma-Aldrich (Poole, UK) unless stated otherwise.
All stock solutions of drugs were made in ethanol (vehicle).
Cells and tissue culture conditions
For this study we used primary human brain microvascular endothelial cells (HBMECs), a fundamental element of the BBB. Cells were used from passage 21-23 and were grown and maintained as previously described (Elsheikha et al., 2013) . When confluent, our HBMECs demonstrated an endothelial morphology with features all typical of a functional endothelium constructed from this cell type (Wong et al., 2004; Colgan et al., 2008; Allen and Bayraktutan, 2009 
Cytotoxicity assays:
Fluorescent microscopy was conducted with a Leica DM5000 (Leica, B Wetzlar, Germany) with images collected and processed with a Leica DFC420 camera and Leica application suite v3.8 software. Since APs have long half-lives, especially in the cases of overdose where their metabolism is changed from 0th to 1st order kinetics (Ereshefsky, 1999) , we performed experiments at four different time points to mimic this: 4hrs, 24hrs, 48hrs and 72hrs post treatment. These longer time periods of incubation were further warranted due to the time-dependence of AP cytotoxicity, often taking at least 48hrs to achieve a maximum effect (Erik et al., 2010) . The lowest concentrations of CPZ and CLZ used in our experiments are near to the top end of therapeutic serum levels for CPZ and CLZ: 0.2-1µM (40-300 ng/ml) and 1-2µM (300-700 ng/ml) respectively, and are similar to those measured in overdosed individuals: . We used these higher concentrations to accelerate and evoke detectable effects of the APs within the time frame of cell division as not to be confounded by affects on cell proliferation. Furthermore, the concentrations used allowed us to mimic overdose scenarios that are clinically experienced.
MTT assay
The MTT assay relies on cellular reduction of the MTT substrate to produce a blue formazan product. As such it is a facile indicator of cell viability that results from the product of cell number and redox status. For this assay we followed the manufacturer protocol (CellTiter 96 Non-Radioactive Cell Proliferation Assay; Promega, UK). Briefly, cells were seeded at 1x10 4 cells per well in 96-well plastic plates (Nunc) and incubated overnight at 37°C under humidified 5% CO2 conditions. To assess chronic effects cells were then incubated for a 4, 24, 48 or 72hrs in the presence of drug or its vehicle. The original drug and vehicle measurements were corrected via subtraction of a blank (media with MTT reagents but without cells). The
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MTT absorbance value is expressed as a percent of the vehicle control (defined as 100%). Each experiment was performed in triplicate, where n represents the number of experiments (triplicates) performed.
Lactate dehydrogenase assay
Plates for this assay were prepared as for MTT, but with lysis by 2% Triton X-100 the positive control. All measurements were corrected via subtraction of a blank (media with reagents but without cells). Leakage of LDH was calculated as a percentage of the Triton X-100 positive control.
Since LDH release was unaffected by vehicle we did not correct for it. Due to degradation of LDH in the media over extended incubation times only 2 time points (4 and 24hrs) were assayed for its release. Each experiment was done in triplicate, where n represents the total number of experiments (triplicates) performed.
Trypan blue exclusion assay
To aid comparison with the MTT assay and determine the number of viable cells we harvested both attached and floating cells for this assay. As the vehicle did not affect the TBE assay we have not corrected for it. Results are expressed as % viability compared to control. Each experiment was done in triplicate per treatment, where n represents the number of experiments (triplicates) performed.
Genotoxicity and apoptotic assays 26
To investigate nuclear/DNA toxic effects of the APs a variety of techniques were used. For these protocols, drug treatment was achieved by incubation of the cells for 24hrs at the EC50 concentration obtained from the respective MTT assay for the APs tested: CPZ, 78µM; HAL, 330µM;
RIS, 300µM and CLZ, 153µM (see Figs. 1 & 2) . For vehicle control, the same volume of ethanol was added as used for drug.
Caspase Assay
To determine the pathway(s) by which APs, may induces apoptosis we evaluated the activities of caspases 3, 8 and 9 after treatment with the APs. These were determined using a BD ApoAlert caspase fluorescent assay kits (Clontech Laboratories, Palo Alto, CA).
Ultrastuctural damage
Nuclear changes indicative of apoptosis were assessed by staining with DAPI and measuring the proportion of cells with chromatin condensation and nuclear fragmentation. Nuclei were considered to have a healthy phenotype when their fluorescence was homogeneously bright, whereas apoptotic nuclei were identified by condensed chromatin at their periphery or a fragmented morphology. For analysis, at least 300 cells from 10 different fields of each treatment were counted and scored blind. Each treatment was repeated at least 3 times. The number of the homogenous (healthy) nuclei was quantified as a percentage of the total nuclei for each experiment. Transmission Electron Microscopy (TEM) was also used to study the structural integrity of cell nuclei.
Comet assay
The alkaline Comet assay is a sensitive method that can detect both single and double stranded DNA breaks. Its "tail" parameters are the most frequently used to describes DNA damage, with the tail moment (TM) and tail DNA (TD) considered the most accurate markers of such damage (De Boeck et al., 2000) . After treatment with APs, cells were harvested in icecold PBS and exposed to 30% ethanol. The infranatant was mixed with agarose and plated onto slides. After lysis, the samples underwent electrophoresis (30 minutes at 300 mA) and stained with propidium iodide (1mg/ml). Cells were imaged by fluorescent microscopy at 546nm excitation and 640nm emission. Images were analysed by Comet score IV software (Perspective Instruments, UK).
Gamma-Histone H2AX
Gamma-Histone H2AX (γH2AX) is another marker for double stranded DNA breaks (Lowndes and Toh, 2005) . For γH2AX staining, cells were grown on glass coverslips for 24 hrs and then treated with APs. values are quoted with 95% confidence intervals. When data was best described by a monophasic relationship, the EC50 of the effect is equal to the IC50, however, when the data was best described by a biphasic relationship the EC50 of the effect was measured empirically.
These procedures were all performed using PRISM 6 (GraphPad Software Inc., San Diego, CA). Statistical significance is defined as P <0.05, and is indicated in the figures as *** for p<0.001, ** for p<0.01 and * for p<0.05.
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